KARLENE DALE: Open Payments
NPI 1750343513 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 7 payments from 6 companies in 2025. Trend: 2023 $122 · 2024 $19 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Baxter Healthcare | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
Products named: ERLEADA, KISQALI, KEYTRUDA, LYNPARZA, PERCLOT, Phesgo.
Industry payments across NY — which companies pay providers there.
